Meat Consumption Linked to Increased Incidence of Type 2 Diabetes
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 27, 2024 -- Consumption of unprocessed red meat, processed meat, and poultry is associated with an increased incidence of type 2 diabetes, according to a study published online in the September issue of The Lancet Diabetes & Endocrinology.
Chunxiao Li, Ph.D., from the University of Cambridge School of Clinical Medicine in the United Kingdom, and colleagues used data from worldwide cohorts and harmonized analytical approaches to examine the associations of unprocessed red meat, processed meat, and poultry consumption with type 2 diabetes. Data were included from 31 cohorts participating in the InterConnect project.
The researchers identified 107,271 incident cases of type 2 diabetes during a median follow-up of 10 years among 1,966,444 adults. Median meat consumption across cohorts was 0 to 110, 0 to 49, and 0 to 72 g/day for unprocessed red meat, processed meat, and poultry, respectively. An increased incidence of type 2 diabetes was seen in association with greater consumption of each of the three types of meat. In North America and in the European and Western Pacific regions, positive associations were seen between meat consumption and type 2 diabetes, while in other regions, the confidence intervals were wide.
"The current findings support the notion that lowering the consumption of unprocessed red meat and processed meat could benefit public health by reducing the incidence of type 2 diabetes," the authors write. "Uncertainty remains regarding the positive association between poultry consumption and the incidence of type 2 diabetes, and this association should be further investigated."
Several authors disclosed ties to dairy associations.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis
TUESDAY, May 13, 2025 -- Patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i) preoperatively have a slightly increased risk for postoperative euglycemic ketoacidosis...
GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients Treated for Obesity
MONDAY, May 12, 2025 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are tied to a reduction in alcohol intake, according to a research letter recently published in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.